Trial intelligence / Profile preview

Anti-toxoplasma drugs for schizophrenia

IRCT201303287373N4Phase 2Completed

Sponsor
Arak University of Medical Sciences
Start
May 2013
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised, triple-blind trial in schizophrenia comparing cotrimoxazole arm with placebo arm (2 arms). Started May 2013; status: completed.

02

Drugs

trimethoprim + sulfamethoxazole
03

Conditions

schizophrenia

Beyond the preview

Go deeper on IRCT201303287373N4.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT201303287373N4.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call